Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Founder of BIOptima Advisors LLC, Elizabeth Adkins Czerepak presently is Chief Financial Officer & Executive Vice President of Sorrento Therapeutics, Inc. and Chief Financial Officer of BeyondSpring, Inc.

She is also on the board of Delcath Systems, Inc. and Member of Licensing Executives Society.

In the past she was CFO, Secretary & EVP-Corporate Development at Altimmune, Inc. and Chief Financial Officer at Altimmune, Inc. (a subsidiary of Altimmune, Inc.), Chief Financial & Business Officer at Isarna Therapeutics, Inc., Managing Director at JPMorgan Chase & Co. Managing Director at Bear, Stearns & Co., Inc. and Managing Partner at Bear Stearns Health Innoventures Management LLC (both are subsidiaries of JPMorgan Chase & Co.), CFO, Secretary & Principal Accounting Officer at Cancer Genetics, Inc., Chief Financial & Business Officer at Genevant Sciences Corp., Principal at Hoffmann-La Roche, Inc., Director & Vice President-Business Development at BASF Pharma Ltd. and Director & Vice President-Business Development at Knoll Pharmaceutical Co.

She received an MBA from Rutgers State University of New Jersey and an undergraduate degree from Marshall University.


Current positions of Elizabeth Adkins Czerepak 
NameTitle Since
Sorrento Therapeutics, Inc.
(Biotechnology & Medical Research)
Chief Financial Officer & Executive Vice President 2022
BeyondSpring Inc.
(Biotechnology & Medical Research)
Chief Financial Officer 2020
Delcath Systems, Inc.
(Medical Equipment, Supplies & Distribution)
Independent Director 2020
Licensing Executives Society Member -


Holdings of Elizabeth Adkins Czerepak 
NameEquities%Valuation
Delcath Systems, Inc. (DCTH)
(Medical Equipment, Supplies & Distribution)
00.0000%0 USD
Sorrento Therapeutics, Inc. (SRNE)
(Biotechnology & Medical Research)
00.0000%0 USD


Elizabeth Adkins Czerepak: Personal Network 
Most Read News 
09/28Buffett's Berkshire Hathaway buys 5.99 million more Occidental shares
RE
09/26Unilever's soap opera: M&A, Nelson Peltz, CEO to retire
RE
09/20JPMorgan CEO Dimon to warn Congress of economic 'storm clouds' -testimony
RE
09/26Twitter to interview Elon Musk, known for combative testimony
RE
09/21Trump ally Barrack's trial on foreign agent charges moves to opening statements
RE
09/28Elon Musk seeks to narrow SEC consent decree, end pre-approval of tweets
RE
09/29The long, winding road to Volkswagen's Porsche IPO
RE
09/20Palihapitiya to wind down two blank-check firms as choppy markets deter valuations
RE
09/21Bloomberg to spend $85 million against U.S. plastic, petrochem buildout
RE
09/21Samsung Elec's Lee says SoftBank's Son expected to visit Seoul -media
RE
More news


© 2022 People and Ownership :   
Elizabeth Adkins Czerepak : Connections